Literature DB >> 3283833

Uterine leiomyomas in the infertile patient: preoperative localization with MR imaging versus US and hysterosalpingography.

C M Dudiak1, D A Turner, S K Patel, J T Archie, B Silver, M Norusis.   

Abstract

Eleven women with a history of infertility and uterine leiomyomas underwent magnetic resonance (MR) imaging of the pelvis prior to myomectomy. Nine also underwent preoperative pelvic ultrasonography (US), and ten underwent hysterosalpingography. All studies were interpreted prospectively by independent observers. With each imaging modality, the location (one of 11 anatomic segments), size, and appearance of detected uterine leiomyomas were determined and compared with surgical and histologic findings. Among the nine patients who underwent both MR and US, the sensitivity (85%) and accuracy (94%) of MR imaging for abnormal segments was significantly better than that of US (sensitivity = 69%, P = .015; accuracy = 87%, P = .043). For the ten patients who underwent both MR and hysterosalpingography, the sensitivity (91%) and accuracy (96%) of MR imaging was better than that of hysterosalpingography (sensitivity = 18%, P = .0005; accuracy = 72%, P = .0005). The specificities of the three modalities did not significantly differ (100%, 97%, and 98% for MR, US, and hysterosalpingography, respectively). These data suggest that MR imaging is superior to US or hysterosalpingography for preoperatively locating uterine leiomyomas.

Entities:  

Mesh:

Year:  1988        PMID: 3283833     DOI: 10.1148/radiology.167.3.3283833

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  [Imaging before and after uterine artery embolization].

Authors:  T J Kröncke
Journal:  Radiologe       Date:  2008-07       Impact factor: 0.635

2.  Increased urinary cobalt and whole blood concentrations of cadmium and lead in women with uterine leiomyomata: Findings from the ENDO Study.

Authors:  Erica B Johnstone; Germaine M Buck Louis; Patrick J Parsons; Amy J Steuerwald; Christopher D Palmer; Zhen Chen; Liping Sun; Ahmad O Hammoud; Jessie Dorais; C Matthew Peterson
Journal:  Reprod Toxicol       Date:  2014-06-30       Impact factor: 3.143

Review 3.  Uterine leiomyomas revisited with review of literature.

Authors:  Rishi Philip Mathew; Swati Francis; Vinayak Jayaram; Shameema Anvarsadath
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

4.  Radiological appearances of uterine fibroids.

Authors:  Sue Wilde; Sarah Scott-Barrett
Journal:  Indian J Radiol Imaging       Date:  2009 Jul-Sep

5.  [Role of magnetic resonance imaging (MRI) in establishing the indication for, planning, and following up uterine artery embolization (UAE) for treating symptomatic leiomyomas of the uterus].

Authors:  T J Kröncke; B Hamm
Journal:  Radiologe       Date:  2003-08       Impact factor: 0.635

6.  Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical care.

Authors:  Eric D Levens; Robert Wesley; Ahalya Premkumar; Wendy Blocker; Lynnette K Nieman
Journal:  Am J Obstet Gynecol       Date:  2009-03-09       Impact factor: 8.661

Review 7.  Management of uterine fibroids in the patient pursuing assisted reproductive technologies.

Authors:  Mohammad Ezzati; John M Norian; James H Segars
Journal:  Womens Health (Lond)       Date:  2009-07

8.  Predictive value of magnetic resonance imaging in differentiating between leiomyoma and adenomyosis.

Authors:  Rosa Moghadam; Ruth B Lathi; Babac Shahmohamady; Naghmeh S Saberi; Ceana H Nezhat; Farr Nezhat; Camran Nezhat
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

9.  Uterine fibroid embolization for symptomatic fibroids: study at a teaching hospital in kenya.

Authors:  John Kiprop Mutai; Sudhir Vinayak; William Stones; Nigel Hacking; Charles Mariara
Journal:  J Clin Imaging Sci       Date:  2015-03-31

Review 10.  Uterine fibroids: current perspectives.

Authors:  Aamir T Khan; Manjeet Shehmar; Janesh K Gupta
Journal:  Int J Womens Health       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.